outcome_descr,brand_descr,stratum,model,model_descr,term,HR,HR_CI,VE,VE_CI,HR_ECI,VE_ECI
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.22,(0.20-0.25),77.5,(74.8-79.9),0.22 (0.20-0.25),77.5 (74.8-79.9)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.32,(0.29-0.35),68.1,(65.4-70.7),0.32 (0.29-0.35),68.1 (65.4-70.7)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.38,(0.36-0.40),62.1,(59.5-64.4),0.38 (0.36-0.40),62.1 (59.5-64.4)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.33,(0.30-0.35),67.2,(64.7-69.5),0.33 (0.30-0.35),67.2 (64.7-69.5)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.27,(0.24-0.29),73.4,(70.8-75.8),0.27 (0.24-0.29),73.4 (70.8-75.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.24,(0.22-0.27),76.0,(73.3-78.4),0.24 (0.22-0.27),76.0 (73.3-78.4)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.21,(0.19-0.23),78.9,(76.8-80.8),0.21 (0.19-0.23),78.9 (76.8-80.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.24,(0.22-0.27),75.9,(73.0-78.4),0.24 (0.22-0.27),75.9 (73.0-78.4)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.35,(0.32-0.38),65.4,(62.4-68.2),0.35 (0.32-0.38),65.4 (62.4-68.2)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.42,(0.39-0.45),58.2,(55.3-60.8),0.42 (0.39-0.45),58.2 (55.3-60.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.37,(0.34-0.40),63.2,(60.4-65.8),0.37 (0.34-0.40),63.2 (60.4-65.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.30,(0.28-0.34),69.5,(66.5-72.3),0.30 (0.28-0.34),69.5 (66.5-72.3)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.28,(0.25-0.31),72.2,(69.0-75.1),0.28 (0.25-0.31),72.2 (69.0-75.1)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.25,(0.22-0.27),75.3,(72.7-77.7),0.25 (0.22-0.27),75.3 (72.7-77.7)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.27,(0.24-0.30),73.5,(70.3-76.3),0.27 (0.24-0.30),73.5 (70.3-76.3)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.38,(0.35-0.42),61.6,(58.3-64.7),0.38 (0.35-0.42),61.6 (58.3-64.7)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.47,(0.44-0.50),53.4,(50.3-56.4),0.47 (0.44-0.50),53.4 (50.3-56.4)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.41,(0.38-0.44),58.9,(55.7-61.8),0.41 (0.38-0.44),58.9 (55.7-61.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.35,(0.32-0.38),65.1,(61.6-68.3),0.35 (0.32-0.38),65.1 (61.6-68.3)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.32,(0.29-0.36),67.8,(64.1-71.1),0.32 (0.29-0.36),67.8 (64.1-71.1)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.29,(0.26-0.32),71.2,(68.1-74.0),0.29 (0.26-0.32),71.2 (68.1-74.0)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.16,(0.14-0.19),83.6,(80.9-85.9),0.16 (0.14-0.19),83.6 (80.9-85.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.25,(0.22-0.27),75.3,(72.5-77.9),0.25 (0.22-0.27),75.3 (72.5-77.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.34,(0.31-0.36),66.5,(63.8-68.9),0.34 (0.31-0.36),66.5 (63.8-68.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.30,(0.28-0.33),69.8,(67.3-72.2),0.30 (0.28-0.33),69.8 (67.3-72.2)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.26,(0.23-0.29),74.3,(71.4-76.9),0.26 (0.23-0.29),74.3 (71.4-76.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.24,(0.22-0.28),75.5,(72.4-78.3),0.24 (0.22-0.28),75.5 (72.4-78.3)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.24,(0.21-0.26),76.5,(73.7-78.9),0.24 (0.21-0.26),76.5 (73.7-78.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.18,(0.16-0.21),81.8,(78.9-84.4),0.18 (0.16-0.21),81.8 (78.9-84.4)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.27,(0.25-0.31),72.5,(69.4-75.4),0.27 (0.25-0.31),72.5 (69.4-75.4)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.38,(0.35-0.41),62.4,(59.4-65.1),0.38 (0.35-0.41),62.4 (59.4-65.1)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.34,(0.31-0.37),66.0,(63.1-68.7),0.34 (0.31-0.37),66.0 (63.1-68.7)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.29,(0.26-0.33),70.5,(67.2-73.5),0.29 (0.26-0.33),70.5 (67.2-73.5)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.28,(0.25-0.32),71.9,(68.2-75.1),0.28 (0.25-0.32),71.9 (68.2-75.1)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.27,(0.24-0.30),73.4,(70.2-76.2),0.27 (0.24-0.30),73.4 (70.2-76.2)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.22,(0.18-0.25),78.5,(74.8-81.7),0.22 (0.18-0.25),78.5 (74.8-81.7)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.32,(0.28-0.35),68.3,(64.6-71.6),0.32 (0.28-0.35),68.3 (64.6-71.6)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.44,(0.41-0.48),55.8,(52.3-59.1),0.44 (0.41-0.48),55.8 (52.3-59.1)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.40,(0.37-0.44),59.6,(56.2-62.8),0.40 (0.37-0.44),59.6 (56.2-62.8)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.37,(0.34-0.42),62.5,(58.3-66.4),0.37 (0.34-0.42),62.5 (58.3-66.4)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.37,(0.33-0.42),63.1,(58.2-67.4),0.37 (0.33-0.42),63.1 (58.2-67.4)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.36,(0.32-0.40),64.1,(59.6-68.0),0.36 (0.32-0.40),64.1 (59.6-68.0)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.35,(0.30-0.42),64.6,(58.2-70.0),0.35 (0.30-0.42),64.6 (58.2-70.0)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.49,(0.42-0.55),51.5,(44.6-57.6),0.49 (0.42-0.55),51.5 (44.6-57.6)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.50,(0.45-0.56),49.9,(43.8-55.4),0.50 (0.45-0.56),49.9 (43.8-55.4)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.45,(0.40-0.52),54.5,(47.9-60.4),0.45 (0.40-0.52),54.5 (47.9-60.4)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.38,(0.32-0.45),62.1,(55.0-68.0),0.38 (0.32-0.45),62.1 (55.0-68.0)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.36,(0.29-0.44),64.1,(56.1-70.7),0.36 (0.29-0.44),64.1 (56.1-70.7)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.38,(0.32-0.45),61.8,(55.0-67.7),0.38 (0.32-0.45),61.8 (55.0-67.7)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.35,(0.30-0.42),64.7,(58.2-70.1),0.35 (0.30-0.42),64.7 (58.2-70.1)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.49,(0.43-0.56),50.8,(43.8-57.0),0.49 (0.43-0.56),50.8 (43.8-57.0)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.52,(0.46-0.58),48.4,(42.0-54.1),0.52 (0.46-0.58),48.4 (42.0-54.1)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.47,(0.41-0.54),52.6,(45.5-58.8),0.47 (0.41-0.54),52.6 (45.5-58.8)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.39,(0.33-0.47),60.6,(53.1-66.9),0.39 (0.33-0.47),60.6 (53.1-66.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.37,(0.30-0.45),63.1,(54.6-69.9),0.37 (0.30-0.45),63.1 (54.6-69.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.39,(0.32-0.46),61.4,(53.9-67.6),0.39 (0.32-0.46),61.4 (53.9-67.6)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.52,(0.40-0.67),48.2,(33.4-59.8),0.52 (0.40-0.67),48.2 (33.4-59.8)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.72,(0.59-0.88),28.0,(12.2-40.9),0.72 (0.59-0.88),28.0 (12.2-40.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.83,(0.72-0.96),16.8,(3.6-28.3),0.83 (0.72-0.96),16.8 (3.6-28.3)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.69,(0.59-0.80),31.1,(19.9-40.9),0.69 (0.59-0.80),31.1 (19.9-40.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.61,(0.49-0.75),39.3,(24.9-50.9),0.61 (0.49-0.75),39.3 (24.9-50.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.56,(0.43-0.74),43.7,(26.4-57.0),0.56 (0.43-0.74),43.7 (26.4-57.0)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.51,(0.40-0.64),49.4,(36.1-59.9),0.51 (0.40-0.64),49.4 (36.1-59.9)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.31,(0.28-0.35),68.7,(64.8-72.2),0.31 (0.28-0.35),68.7 (64.8-72.2)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.35,(0.32-0.38),65.2,(61.6-68.5),0.35 (0.32-0.38),65.2 (61.6-68.5)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.39,(0.36-0.42),60.8,(57.7-63.7),0.39 (0.36-0.42),60.8 (57.7-63.7)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.32,(0.29-0.35),68.4,(65.5-71.0),0.32 (0.29-0.35),68.4 (65.5-71.0)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.24,(0.21-0.27),76.3,(73.4-78.9),0.24 (0.21-0.27),76.3 (73.4-78.9)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.20,(0.17-0.23),80.2,(77.4-82.7),0.20 (0.17-0.23),80.2 (77.4-82.7)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.17,(0.15-0.19),83.1,(81.1-85.0),0.17 (0.15-0.19),83.1 (81.1-85.0)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.34,(0.30-0.38),66.3,(62.1-70.1),0.34 (0.30-0.38),66.3 (62.1-70.1)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.38,(0.34-0.42),62.2,(58.2-65.7),0.38 (0.34-0.42),62.2 (58.2-65.7)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.43,(0.40-0.47),56.5,(53.0-59.8),0.43 (0.40-0.47),56.5 (53.0-59.8)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.36,(0.33-0.39),64.2,(60.9-67.3),0.36 (0.33-0.39),64.2 (60.9-67.3)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.27,(0.24-0.31),72.5,(69.1-75.5),0.27 (0.24-0.31),72.5 (69.1-75.5)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.23,(0.20-0.27),76.8,(73.4-79.8),0.23 (0.20-0.27),76.8 (73.4-79.8)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.20,(0.18-0.23),80.1,(77.5-82.3),0.20 (0.18-0.23),80.1 (77.5-82.3)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.42,(0.36-0.49),57.9,(51.0-63.8),0.42 (0.36-0.49),57.9 (51.0-63.8)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.46,(0.41-0.51),54.1,(48.5-59.1),0.46 (0.41-0.51),54.1 (48.5-59.1)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.51,(0.47-0.56),48.8,(44.2-52.9),0.51 (0.47-0.56),48.8 (44.2-52.9)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.42,(0.38-0.47),57.7,(53.2-61.8),0.42 (0.38-0.47),57.7 (53.2-61.8)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.33,(0.29-0.37),67.3,(63.2-70.9),0.33 (0.29-0.37),67.3 (63.2-70.9)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.28,(0.25-0.32),71.8,(67.6-75.5),0.28 (0.25-0.32),71.8 (67.6-75.5)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.25,(0.22-0.28),75.4,(72.2-78.3),0.25 (0.22-0.28),75.4 (72.2-78.3)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.20,(0.17-0.24),79.6,(75.9-82.7),0.20 (0.17-0.24),79.6 (75.9-82.7)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.29,(0.25-0.32),71.3,(67.5-74.6),0.29 (0.25-0.32),71.3 (67.5-74.6)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.34,(0.31-0.37),66.1,(62.9-69.0),0.34 (0.31-0.37),66.1 (62.9-69.0)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.29,(0.26-0.32),71.1,(68.1-73.9),0.29 (0.26-0.32),71.1 (68.1-73.9)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.23,(0.20-0.26),76.8,(73.5-79.7),0.23 (0.20-0.26),76.8 (73.5-79.7)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.20,(0.17-0.24),79.7,(76.3-82.7),0.20 (0.17-0.24),79.7 (76.3-82.7)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.20,(0.18-0.23),79.9,(77.0-82.4),0.20 (0.18-0.23),79.9 (77.0-82.4)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.23,(0.19-0.27),77.1,(73.0-80.7),0.23 (0.19-0.27),77.1 (73.0-80.7)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.32,(0.29-0.37),67.6,(63.3-71.3),0.32 (0.29-0.37),67.6 (63.3-71.3)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.39,(0.35-0.42),61.3,(57.6-64.7),0.39 (0.35-0.42),61.3 (57.6-64.7)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.33,(0.30-0.37),66.8,(63.3-70.0),0.33 (0.30-0.37),66.8 (63.3-70.0)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.27,(0.24-0.31),72.8,(68.9-76.2),0.27 (0.24-0.31),72.8 (68.9-76.2)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.24,(0.20-0.28),76.2,(72.1-79.7),0.24 (0.20-0.28),76.2 (72.1-79.7)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.23,(0.20-0.26),77.0,(73.5-80.0),0.23 (0.20-0.26),77.0 (73.5-80.0)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.35,(0.27-0.45),65.3,(55.1-73.2),0.35 (0.27-0.45),65.3 (55.1-73.2)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.40,(0.34-0.47),60.1,(53.5-65.8),0.40 (0.34-0.47),60.1 (53.5-65.8)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.46,(0.42-0.51),53.8,(49.1-58.2),0.46 (0.42-0.51),53.8 (49.1-58.2)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.40,(0.35-0.46),59.6,(53.9-64.6),0.40 (0.35-0.46),59.6 (53.9-64.6)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.33,(0.29-0.38),66.6,(61.8-70.9),0.33 (0.29-0.38),66.6 (61.8-70.9)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.30,(0.26-0.35),70.0,(64.8-74.4),0.30 (0.26-0.35),70.0 (64.8-74.4)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.30,(0.26-0.35),70.1,(65.4-74.1),0.30 (0.26-0.35),70.1 (65.4-74.1)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.56,(0.47-0.66),44.0,(33.9-52.6),0.56 (0.47-0.66),44.0 (33.9-52.6)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.48,(0.41-0.57),51.9,(43.4-59.1),0.48 (0.41-0.57),51.9 (43.4-59.1)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.54,(0.48-0.62),45.6,(37.8-52.3),0.54 (0.48-0.62),45.6 (37.8-52.3)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.47,(0.40-0.55),53.4,(45.4-60.3),0.47 (0.40-0.55),53.4 (45.4-60.3)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.36,(0.30-0.45),63.5,(55.4-70.2),0.36 (0.30-0.45),63.5 (55.4-70.2)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.33,(0.26-0.43),66.5,(57.4-73.7),0.33 (0.26-0.43),66.5 (57.4-73.7)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.30,(0.25-0.36),70.0,(63.5-75.3),0.30 (0.25-0.36),70.0 (63.5-75.3)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.56,(0.47-0.66),44.2,(34.1-52.8),0.56 (0.47-0.66),44.2 (34.1-52.8)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.49,(0.41-0.57),51.4,(42.8-58.7),0.49 (0.41-0.57),51.4 (42.8-58.7)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.56,(0.49-0.64),44.0,(35.9-51.1),0.56 (0.49-0.64),44.0 (35.9-51.1)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.48,(0.41-0.57),51.7,(43.1-58.9),0.48 (0.41-0.57),51.7 (43.1-58.9)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.38,(0.31-0.46),62.3,(53.7-69.3),0.38 (0.31-0.46),62.3 (53.7-69.3)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.34,(0.27-0.44),65.8,(56.3-73.3),0.34 (0.27-0.44),65.8 (56.3-73.3)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.30,(0.25-0.37),69.8,(62.9-75.5),0.30 (0.25-0.37),69.8 (62.9-75.5)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.68,(0.55-0.84),32.2,(16.3-45.1),0.68 (0.55-0.84),32.2 (16.3-45.1)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.60,(0.50-0.73),39.8,(27.0-50.3),0.60 (0.50-0.73),39.8 (27.0-50.3)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.80,(0.67-0.96),19.8,(4.4-32.7),0.80 (0.67-0.96),19.8 (4.4-32.7)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.62,(0.51-0.75),38.0,(25.1-48.7),0.62 (0.51-0.75),38.0 (25.1-48.7)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.49,(0.38-0.62),51.0,(37.6-61.6),0.49 (0.38-0.62),51.0 (37.6-61.6)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.43,(0.33-0.56),56.8,(43.8-66.8),0.43 (0.33-0.56),56.8 (43.8-66.8)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.39,(0.31-0.48),61.4,(51.8-69.1),0.39 (0.31-0.48),61.4 (51.8-69.1)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.13,(0.11-0.15),86.7,(84.6-88.6),0.13 (0.11-0.15),86.7 (84.6-88.6)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.17,(0.15-0.19),83.0,(81.0-84.8),0.17 (0.15-0.19),83.0 (81.0-84.8)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.19,(0.18-0.21),80.8,(79.3-82.3),0.19 (0.18-0.21),80.8 (79.3-82.3)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.22,(0.21-0.24),77.7,(76.0-79.3),0.22 (0.21-0.24),77.7 (76.0-79.3)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.23,(0.21-0.25),77.0,(75.1-78.8),0.23 (0.21-0.25),77.0 (75.1-78.8)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.21,(0.19-0.23),79.3,(77.4-80.9),0.21 (0.19-0.23),79.3 (77.4-80.9)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.21,(0.20-0.22),79.0,(77.5-80.4),0.21 (0.20-0.22),79.0 (77.5-80.4)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.14,(0.12-0.16),86.3,(84.1-88.2),0.14 (0.12-0.16),86.3 (84.1-88.2)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.18,(0.16-0.20),82.3,(80.2-84.2),0.18 (0.16-0.20),82.3 (80.2-84.2)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.20,(0.19-0.22),79.8,(78.1-81.3),0.20 (0.19-0.22),79.8 (78.1-81.3)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.24,(0.22-0.26),76.3,(74.4-78.0),0.24 (0.22-0.26),76.3 (74.4-78.0)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.24,(0.23-0.26),75.5,(73.5-77.4),0.24 (0.23-0.26),75.5 (73.5-77.4)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.22,(0.20-0.24),78.1,(76.2-79.9),0.22 (0.20-0.24),78.1 (76.2-79.9)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.22,(0.20-0.23),78.4,(76.8-79.9),0.22 (0.20-0.23),78.4 (76.8-79.9)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.22,(0.17-0.28),78.0,(72.0-82.6),0.22 (0.17-0.28),78.0 (72.0-82.6)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.28,(0.24-0.33),71.6,(66.6-75.9),0.28 (0.24-0.33),71.6 (66.6-75.9)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.31,(0.28-0.34),68.9,(65.7-71.9),0.31 (0.28-0.34),68.9 (65.7-71.9)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.37,(0.34-0.40),63.2,(60.0-66.2),0.37 (0.34-0.40),63.2 (60.0-66.2)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.39,(0.36-0.43),60.6,(56.9-64.0),0.39 (0.36-0.43),60.6 (56.9-64.0)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.37,(0.33-0.41),63.2,(59.1-66.8),0.37 (0.33-0.41),63.2 (59.1-66.8)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.34,(0.31-0.37),66.1,(63.3-68.7),0.34 (0.31-0.37),66.1 (63.3-68.7)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.07,(0.06-0.09),92.9,(90.8-94.5),0.07 (0.06-0.09),92.9 (90.8-94.5)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.09,(0.07-0.11),91.3,(89.5-92.8),0.09 (0.07-0.11),91.3 (89.5-92.8)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.10,(0.09-0.12),89.5,(88.2-90.7),0.10 (0.09-0.12),89.5 (88.2-90.7)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.13,(0.12-0.15),86.7,(85.3-88.0),0.13 (0.12-0.15),86.7 (85.3-88.0)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.16,(0.15-0.18),83.5,(81.8-85.1),0.16 (0.15-0.18),83.5 (81.8-85.1)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.14,(0.13-0.16),86.0,(84.4-87.4),0.14 (0.13-0.16),86.0 (84.4-87.4)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.21,(0.19-0.22),79.3,(77.7-80.8),0.21 (0.19-0.22),79.3 (77.7-80.8)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.08,(0.06-0.10),92.0,(89.6-93.8),0.08 (0.06-0.10),92.0 (89.6-93.8)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.10,(0.08-0.12),90.0,(88.0-91.7),0.10 (0.08-0.12),90.0 (88.0-91.7)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.12,(0.11-0.14),87.9,(86.4-89.3),0.12 (0.11-0.14),87.9 (86.4-89.3)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.15,(0.14-0.17),84.7,(83.1-86.2),0.15 (0.14-0.17),84.7 (83.1-86.2)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.19,(0.17-0.21),81.1,(79.1-83.0),0.19 (0.17-0.21),81.1 (79.1-83.0)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.16,(0.14-0.18),84.2,(82.4-85.9),0.16 (0.14-0.18),84.2 (82.4-85.9)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.22,(0.20-0.23),78.5,(76.7-80.1),0.22 (0.20-0.23),78.5 (76.7-80.1)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.13,(0.09-0.20),86.6,(80.2-90.9),0.13 (0.09-0.20),86.6 (80.2-90.9)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.19,(0.13-0.28),80.8,(71.9-86.8),0.19 (0.13-0.28),80.8 (71.9-86.8)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.22,(0.18-0.27),77.6,(72.6-81.7),0.22 (0.18-0.27),77.6 (72.6-81.7)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.27,(0.24-0.31),73.1,(69.3-76.4),0.27 (0.24-0.31),73.1 (69.3-76.4)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.36,(0.32-0.40),64.3,(60.3-67.8),0.36 (0.32-0.40),64.3 (60.3-67.8)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.31,(0.28-0.35),69.0,(65.2-72.4),0.31 (0.28-0.35),69.0 (65.2-72.4)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.42,(0.38-0.46),58.3,(54.2-62.0),0.42 (0.38-0.46),58.3 (54.2-62.0)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.20,(0.16-0.23),80.4,(76.5-83.7),0.20 (0.16-0.23),80.4 (76.5-83.7)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.26,(0.23-0.30),74.1,(70.3-77.4),0.26 (0.23-0.30),74.1 (70.3-77.4)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.29,(0.26-0.33),70.7,(67.5-73.6),0.29 (0.26-0.33),70.7 (67.5-73.6)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.35,(0.31-0.38),65.3,(61.6-68.5),0.35 (0.31-0.38),65.3 (61.6-68.5)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.33,(0.29-0.37),67.2,(63.5-70.6),0.33 (0.29-0.37),67.2 (63.5-70.6)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.36,(0.32-0.40),63.8,(59.5-67.7),0.36 (0.32-0.40),63.8 (59.5-67.7)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.40,(0.37-0.44),59.6,(56.0-62.9),0.40 (0.37-0.44),59.6 (56.0-62.9)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.18,(0.15-0.22),81.7,(78.1-84.8),0.18 (0.15-0.22),81.7 (78.1-84.8)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.24,(0.21-0.28),75.7,(72.1-78.8),0.24 (0.21-0.28),75.7 (72.1-78.8)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.28,(0.25-0.30),72.5,(69.5-75.2),0.28 (0.25-0.30),72.5 (69.5-75.2)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.32,(0.29-0.36),67.8,(64.4-70.9),0.32 (0.29-0.36),67.8 (64.4-70.9)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.30,(0.27-0.33),70.3,(66.9-73.4),0.30 (0.27-0.33),70.3 (66.9-73.4)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.32,(0.29-0.36),68.1,(64.2-71.5),0.32 (0.29-0.36),68.1 (64.2-71.5)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.35,(0.32-0.38),65.1,(61.8-68.2),0.35 (0.32-0.38),65.1 (61.8-68.2)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.31,(0.24-0.40),68.7,(59.9-75.5),0.31 (0.24-0.40),68.7 (59.9-75.5)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.44,(0.37-0.52),56.4,(47.9-63.5),0.44 (0.37-0.52),56.4 (47.9-63.5)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.51,(0.44-0.59),48.9,(41.1-55.6),0.51 (0.44-0.59),48.9 (41.1-55.6)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.63,(0.55-0.71),37.5,(29.3-44.7),0.63 (0.55-0.71),37.5 (29.3-44.7)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.56,(0.49-0.64),44.3,(36.4-51.1),0.56 (0.49-0.64),44.3 (36.4-51.1)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.60,(0.52-0.68),40.5,(31.6-48.2),0.60 (0.52-0.68),40.5 (31.6-48.2)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.62,(0.56-0.69),37.9,(30.7-44.4),0.62 (0.56-0.69),37.9 (30.7-44.4)
